UK Space Agency Funds Projects for In-Orbit Manufacturing of Cancer Drugs and Semiconductors
The UK Space Agency is funding three companies to explore in-orbit manufacturing of advanced materials and medicines. Space Forge Ltd aims to grow semiconductor seed crystals in microgravity, OrbiSky Ltd is testing production of ZBLAN glass for superior optical fibres, and BioOrbit Ltd is developing a system for manufacturing cancer drugs in space. These projects leverage unique orbital conditions to create products that could revolutionize pharmaceuticals and technology on Earth.
Theia Market Signal Identification - AI Assisted
The UK Space Agency has initiated contracts with three companies to explore the potential of low Earth orbit for innovative manufacturing. Space Forge Ltd is focusing on growing semiconductor seed crystals in microgravity, enhancing the efficiency and reliability of electronics.
OrbiSky Ltd is experimenting with ZBLAN fluoride glass to produce optical fibres with significantly lower signal loss, which could improve telecommunications. BioOrbit Ltd plans to manufacture cancer drugs in space, producing ideal protein crystals. These projects are supported by the agency's Sustainability & ISAM and Unlocking Space programmes, aiming to position the UK as a leader in space-based innovation.
Comments